Christos Sachpekidis

Christos Sachpekidis

Heidelberg, BW 69210, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

High-contrast somatostatin receptor imaging of meningiomas with [¹⁸F]SiTATE PET/CT.

High-contrast somatostatin receptor imaging of meningiomas with [¹⁸F]SiTATE PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 25, 2026

Interpreting [18F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial.

Interpreting [18F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 20, 2026

Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT.

Are liver metastases from uveal melanoma a clinical indication for dynamic PET? A comparison of Patlak parametric imaging with standard and delayed static SUV imaging using long axial field-of-view PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 08, 2026

Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [1⁸F]FDG PET/CT metrics in metastatic melanoma.

Beyond target lesions: Prognostic value of longitudinal AI-derived whole-body [1⁸F]FDG PET/CT metrics in metastatic melanoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 18, 2026

Chrónos and Káiros in theragnostics: re-assessing time toxicity in final-line radiopharmaceutical treatments.

Chrónos and Káiros in theragnostics: re-assessing time toxicity in final-line radiopharmaceutical treatments.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 04, 2026

Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation.

Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation.

Journal: EJNMMI physics

Published: December 08, 2025

The Role of FAPI-PET in Evaluating Suspected Liposarcoma: A Case on the Diagnostic Potential.

The Role of FAPI-PET in Evaluating Suspected Liposarcoma: A Case on the Diagnostic Potential.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: September 29, 2025

Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial.

Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 07, 2025

Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [18F]FDG PET/CT study.

Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [18F]FDG PET/CT study.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 02, 2025

Representation Learning in PET Scans Enhanced by Semantic and 3D Position Specific Characteristics.

Representation Learning in PET Scans Enhanced by Semantic and 3D Position Specific Characteristics.

Journal: IEEE transactions on medical imaging

Published: May 05, 2025

Staging and treatment response assessment with radiological and nuclear medicine approaches for non-Hodgkin lymphomas

Staging and treatment response assessment with radiological and nuclear medicine approaches for non-Hodgkin lymphomas

Journal: Radiologie (Heidelberg, Germany)

Published: April 22, 2025

Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.

Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 21, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026